O explore gone.love in elderly patients with hypertension pulse pressure. In routine therapy achiees basis o served in yesterday by the elderly patients with hypertension, pulse pressure. After 10 months of clinical observation and comparison conventional step-down + mo company group (acyclovir N68) and conventional step-down N64 group (group), detection, and DBP SBP before and after treatment, PP, TG changes
The research is on the effects of Acipimox on pulse pressures of senior hypertension patients and the effects of additional Acipimox with conventional antihypertensive therapy on senior hypertension patients with broadened pulse pressures. After 10 months of clinical comparative observation on team N68 (conventional antihypertensive therapy with Acipimox) against team N64 (conventional antihypertensive therapy only), both teams' changes in SBP、DBP、PP、TG before and after treatment are monitored.